NASDAQ · HBIO
Harvard Bioscience, Inc.
U.S. listed stock · USD15-minute delay
Find an instrument
- AppleAAPL · NASDAQResearch →
- MicrosoftMSFT · NASDAQResearch →
- NvidiaNVDA · NASDAQResearch →
- AmazonAMZN · NASDAQResearch →
- AlphabetGOOGL · NASDAQResearch →
- Meta PlatformsMETA · NASDAQResearch →
- TeslaTSLA · NASDAQResearch →
- JPMorgan ChaseJPM · NYSEResearch →
- ExxonMobilXOM · NYSEResearch →
- WalmartWMT · NASDAQResearch →
- S&P 500 IndexSPX · S&PResearch →
- Nasdaq 100 IndexNDX · NASDAQResearch →
- Dow Jones Industrial AverageDJI · Dow JonesResearch →
- Cboe Volatility IndexVIX · CboeResearch →
- U.S. Dollar IndexDXY · ICEResearch →
- VIX futuresVX1! · Cboe Futures ExchangeResearch →
- DAX futuresFDAX1! · EurexResearch →
- Euro Stoxx 50 futuresFESX1! · EurexResearch →
- E-mini S&P 500 futuresES1! · CMEResearch →
- E-mini Nasdaq 100 futuresNQ1! · CMEResearch →
- E-mini Dow futuresYM1! · CBOTResearch →
- E-mini Russell 2000 futuresRTY1! · CMEResearch →
- WTI crude oil futuresCL1! · NYMEXResearch →
- Natural gas futuresNG1! · NYMEXResearch →
- Gold futuresGC1! · COMEXResearch →
- Silver futuresSI1! · COMEXResearch →
- Euro FX futures6E1! · CMEResearch →
- Japanese yen futures6J1! · CMEResearch →
- BitcoinBTCUSD · BitstampResearch →
- EtherETHUSD · BitstampResearch →
- Research Any U.S. stock or ETF tickerResearch →
No matching names. Type a U.S. stock ticker (for example MU) to research it.
Loading price chart…
Price chart by TradingView
15-minute delay. Chart times and available timeframes are controlled by the provider.
Earnings
Earnings calendarEarnings announcement for HBIO: Nov 10, 2026
Harvard Bioscience, Inc. Common Stock is expected to report earnings on 11/10/2026 before market open. The report will be for the fiscal Quarter ending Sep 2026. The reported EPS for the same quarter last year was $-0.1.
Source: Nasdaq, based on Zacks Investment Research consensus estimates. Dates marked as expected may change.
News
The Motley Fool · RTTNews · Fintel · Quiver Quantitative- The Motley Fool · Aug 18, 9:42 AM EDTHarvard Bioscience (HBIO) Q2 2026 Earnings Call Transcript@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo
- RTTNews · Aug 11, 9:34 AM EDTHarvard Bioscience's Q2 Revenue Rises 11%; Raises FY26 Growth Outlook(RTTNews) – Harvard Bioscience, Inc. (HBIO), a provider of technologies and products supporting life science research, has announced its financial results for the second quarter ended June 30, 2026.
- The Motley Fool · May 12, 12:37 PM EDTHBIO Q1 2026 Earnings Transcript@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo
- Fintel · Mar 27, 4:43 PM EDTHarvard Bioscience (HBIO) Price Target Increased by 200.00% to 6.12The average one-year price target for Harvard Bioscience (NasdaqCM:HBIO) has been revised to $6.12 / share. This is an increase of 200.00% from the prior estimate of $2.04 dated February 21, 2026. The price target is an average of many targets provided by anal
- The Motley Fool · Mar 12, 10:19 AM EDTHarvard Bioscience (HBIO) Earnings Transcript@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo
- RTTNews · Mar 8, 8:50 PM EDTHarvard Bioscience Sets 1-for-10 Reverse Stock Split; Shares Drop 12% Overnight(RTTNews) – Harvard Bioscience, Inc. (HBIO), a provider of specialized life-science research instruments, announced for a 1-for-10 reverse stock split that will take effect on March 13, 2026, with split-adjusted trading beginning March 16, 2026.
- The Motley Fool · Aug 11, 7:12 AM EDTHarvard Bioscience Tops Q2 Revenue ViewsGAAP revenue of $20.5 million in Q2 2025 surpassed analyst expectations by 9.3%, despite a decline from the same period in 2024.
- RTTNews · Jul 17, 7:57 AM EDTHarvard Bioscience Appoints John Duke As Chief Executive Officer; Ups Q2 Revenue Outlook(RTTNews) – Harvard Bioscience, Inc. (HBIO), a maker of life sciences equipment to support research and drug discovery, said on Thursday that it has appointed John Duke as Chief Executive Officer to succeed retiring Jim Green with effect from July 28.
- Quiver Quantitative · Jul 17, 7:13 AM EDTHarvard Bioscience Announces John Duke as New President & CEO Following Jim Green's Retirement and Appoints Rob Gagnon and Seth Benson to Board of DirectorsJohn Duke will become President & CEO of Harvard Bioscience on July 28, 2025, succeeding Jim Green.
- Quiver Quantitative · Jun 2, 5:00 PM EDTHarvard Bioscience Appoints John Duke to Board of Directors and Names Katherine Eade Lead Independent DirectorHarvard Bioscience appointed John Duke to its board, naming Katherine Eade as Lead Independent Director.
- Quiver Quantitative · May 12, 7:30 AM EDTHARVARD BIOSCIENCE Earnings Results: $HBIO Reports Quarterly EarningsHARVARD BIOSCIENCE ($HBIO) posted quarterly earnings results on Monday, May 12th. The company reported earnings of -$0.01 per share, beating estimates of -$0.04 by $0.03. The company also reported revenue of $21,770,000, beating estimates of $19,584,000 by $2,186,000.
- Quiver Quantitative · May 5, 4:51 PM EDTHarvard Bioscience, Inc. to Announce Q1 2025 Financial Results on May 12, 2025Harvard Bioscience will announce Q1 2025 financial results on May 12, 2025, followed by a conference call.
Stories from Nasdaq.com, including Zacks, The Motley Fool and Barchart. They open on the publisher’s site; AiFs Market does not edit or endorse them.
Company profile
Loading company profile…
Company profile by TradingView
Financials
Loading fundamental data…
Fundamental data by TradingView
More headlines
More stories for Harvard Bioscience, Inc. from TradingView. Coverage varies.
Loading related news…
Related news by TradingView
Quotes, charts, company information and headlines are supplied by TradingView. Data may be delayed or unavailable. This page is for market research and does not provide investment advice.